What is AMGN(Amgen) average time for price targets to be met?

On average it took 572.45 days on average for the stock forecasts to be realized with a an average price target met ratio 87.94.

AMGN - Amgen Stock - Displayed [523 Analyst Price Targets]

AMGN - Amgen - Stock Forecast

Healthcare - Sector

Coverage Profile Stock analysts Price Targets & Ratings Chart Insider Trading

AMGN is currently covered by 24 analysts with an average price target of $305.6. This is a potential upside of $33.91 (12.48%) from yesterday's end of day stock price of $271.69.

Amgen's activity chart (see below) currently has 523 price targets and 473 ratings on display. The stock rating distribution of AMGN is 52.81% BUY, 8.99% SELL and 38.2% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.94% with an average time for these price targets to be met of 572.45 days.

Highest price target for AMGN is $380, Lowest price target is $215, average price target is $311.2.

Most recent stock forecast was given by SALIM SYED from MIZUHO on 07-May-2025.

What is Amgen?

Amgen is a biotechnology company that specializes in developing, manufacturing, and delivering human therapeutics.

The company’s research focuses on six main therapeutic areas, which include inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.

Products

Amgen produces drugs such as Enbrel, Neulasta, Prolia, Xgeva, Aranesp, KYPROLIS, and Repatha, which treat anemia, cardiovascular disease, multiple myeloma, osteoporosis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.

Enbrel
- Treats inflammatory conditions such as plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis. A healthcare provider or the patient injects Enbrel to inhibit tumor necrosis factor (TNF).
Neulasta
- This product reduces the risk of infection in cancer patients undergoing chemotherapy, by stimulating the bone marrow to produce more white blood cells. It is administered by injection, usually 24 hours after chemotherapy.
Prolia
- Treats postmenopausal women with osteoporosis by inhibiting RANKL, a protein involved in bone tissue breakdown. It is given by injection every six months. Prolia can increase bone density and reduce fractures.

History

Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.

Amgen in the News

PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co

Insights from the First Quarter of 2025 PRIMECAP Management (Trades, Portfolio) recently submitted its 13F filing for the first quarter of 2025, offering a glimpse into its strategic investment decisions. Founded in 1983 in Pasadena, CA, PRIMECAP Management (Trades, Portfolio) is an independent investment management company that focuses on U.S.-based equity portfolios for a select...

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif., May 9, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Wednesday, May 14, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jay Bradner, executive vice president of Research and Development and chief scientific officer at Amgen, will present at the...